• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Rabbit polyclonal to Smad7

The advancement of chemoresistance in patients represents a main challenge in

February 18, 2018 by Katherine Lewis Leave a Comment

The advancement of chemoresistance in patients represents a main challenge in cancer treatment. cisplatin and/or Taxol in dental squamous cells was examined. Cell viability was examined by MTT assay, LDHA expression was analyzed by traditional western mark siRNA and analysis tranfection was performed to knock 708219-39-0 manufacture straight down LDHA expression. The present research outcomes … [Read more…]

Posted in: Blogging Tagged: 708219-39-0 manufacture, Rabbit polyclonal to Smad7

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by